# Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome

> **NIH NIH R21** · ADA FORSYTH INSTITUTE, INC. · 2022 · $248,750

## Abstract

PROJECT SUMMARY
Sjӧgren’s syndrome is an autoimmune disease that causes chronic inflammation and damage/dysfunction of
salivary and lacrimal glands, with hyposalivation as one of the main clinical manifestations. The disease greatly
compromises the oral and systemic health of 4 million Americans, mostly women, with no cure or effective
biological therapy. Stem cell therapies hold great promise for Sjӧgren’s disease, but the chronic autoimmune
inflammation greatly impedes the likelihood of success. There is a critical need for new strategies and methods
for attenuation of autoimmune inflammation achieve effective and sustained regeneration of the damaged and
dysfunctional salivary glands. The objective of this exploratory project to elucidate the impact of specialized pro-
resolving mediators (SPMs) on the expansion, renewal and immune-regulatory activity of salivary gland stem
cells both in vitro and in vivo. SPMs are pro-resolving lipid mediators that mediate active resolution of
inflammation and have demonstrated abilities to enhance the immunomodulatory, pro-healing and regenerative
properties of stem cells. Moreover, SPMs can also be produced by stem cells. Our preliminary studies provided
compelling evidence that SPMs positively impact both the stem cell activity and the immune-regulatory property
of mouse salivary gland stem cells. Our innovative central hypothesis is that SPMs can promote sustainable
structural and functional restoration of damaged salivary glands in Sjӧgren’s disease setting by acting on both
salivary gland stem cells and immune/inflammatory cells to simultaneously mitigate autoimmune inflammation
and enhance tissue regeneration. In Aim 1, we will examine whether lipoxin A4 and maresin-1 can boost the
renewal, expansion, salivary organoid formation, SPM production and immune-regulatory activity of salivary
gland stem cells from normal C57BL/6 mice in Matrigel-based expansion and differentiation culture systems. In
Aim 2, we will determine if these SPMs can promote the structural and functional restoration of damaged salivary
glands in Sjӧgren’s disease condition in vivo. Specifically, we will assess whether lipoxin A4 and maresin-1
administered to Sjӧgren’s disease-afflicted mice transplanted with salivary gland stem cells can simultaneously
attenuate inflammation and enhance tissue regeneration, thereby achieving sustainable structural and functional
restoration of salivary glands. Major methodologies employed in this project include Matrigel culture, intra-
salivary gland cell transfer, high-throughput RNA-sequencing and bioinformatics, flow cytometry, real-time qPCR,
immunohistochemistry and Luminex assay. Completion of this innovative exploratory project will elucidate the
actions of SPMs in salivary gland stem cell-mediated tissue regeneration in the Sjögren’s disease condition. It
will advance the development of stem cell therapies that concomitantly attenuate autoimmune inflammation and
enhance tissue regeneration ...

## Key facts

- **NIH application ID:** 10528045
- **Project number:** 1R21DE031058-01A1
- **Recipient organization:** ADA FORSYTH INSTITUTE, INC.
- **Principal Investigator:** Qing Yu
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $248,750
- **Award type:** 1
- **Project period:** 2022-07-01 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10528045

## Citation

> US National Institutes of Health, RePORTER application 10528045, Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome (1R21DE031058-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10528045. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*